Supporting Statement: Part B
Evaluation of the Action Plan for the
National Public Health Initiative on Diabetes and Women’s Health
Supported by:
Division of Diabetes Translation
National Center for Chronic Disease Prevention
and Health Promotion
Centers for Disease Control and Prevention
U.S. Public Health Service
Department of Health and Human Services
November 5, 2009
Government Project Officer:
Michelle D. Owens-Gary, Ph.D.
Centers for Disease Control and Prevention
4770 Buford Highway, NE
MS K-10
Atlanta, GA 30341
Telephone: 770-488-5014
Fax: 770-488-5195
Email: MOwens1@cdc.gov
Table of Contents
Part B: Collection of Information Employing Statistical Methods
B1. Respondent Universe and Sampling Methods
B2. Procedures for Collection of Information
B3. Methods to Maximize Response Rates and Deal with Nonresponse
B4. Tests of Procedures or Methods to be Undertaken
B5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data
Attachments
Attachment A. Authorizing Legislation
Attachment B. Federal Register Notice
Attachment C. Description of the National Public Health Initiative on Diabetes and Women’s Health
Attachment D. Partner Survey
Attachment D1. Partner Invitation
Attachment D2. Partner Reminder
Attachment E. Co-sponsor Survey
Attachment E1. Co-sponsor Invitation
Attachment E2. Co-sponsor Reminder
Part B: Collection of Information Employing Statistical Methods
B1. Respondent Universe and Sampling Methods
Partners and co-sponsors of the Initiative will be invited to participate in an online survey to determine which activities and/or programs have been developed or implemented to address the priority areas outlined by the Initiative. The universe of possible participants in the online survey is expected to be 124, with 100 participants representing private organizations, 20 participants representing state and local government partners, and 4 participants representing the co-sponsors of the Initiative (AADE, ADA, APHA, ASTHO). Our goal is to achieve a response rate of 70%.
The data collected from the online survey will be aggregated to develop a report for partners. Descriptive analyses will be conducted.
B2. Procedures for Collection of Information
One-hundred twenty-four partners of the Initiative will be recruited to participate in an online survey (see Attachments D and E). Recruitment will begin as soon as possible after notification of OMB approval. Partners of the Initiative will be informed of the availability of the online survey by mail (see Attachments D1 and E1). The letter will describe the purpose of the online survey and how partners can access the survey on-line. Information will be collected electronically through Survey Monkey, a web-based survey system.
B3. Methods to Maximize Response Rates and Deal with Nonresponse
A letter informing partners of the Initiative about the online survey will be mailed to encourage their participation in the survey. Partners will be informed of the purpose of the survey, how to access the survey, and the length of time that the survey will be available. A reminder letter (see Attachments D2 and E2) will also be sent to remind partners about the availability of the survey. Incentives will not be offered for survey responders.
B4. Tests of Procedures or Methods to be Undertaken
The draft survey was pilot tested by a small sample of 5 respondents who provided input on the format of the survey, clarity, and the burden estimate for completing the survey.
B5. Individuals Consulted on Statistical Aspects and Individual Collecting And/Or Analyzing Data
The survey was designed and reviewed by two CDC staff with expertise in evaluation.
Ana Alfaro-Correa, MSc
Centers for Disease Control and Prevention
Division of Diabetes Translation
4770 Buford Highway, NE
Atlanta, GA 30341
Phone: 770-488-5676
Email: AAlfaro-Correa@cdc.gov
Keri Norris, PhD
Centers for Disease Control and Prevention
Division of Diabetes Translation
4770 Buford Highway, NE
Atlanta, GA 30341
Phone: 770-488-3091
Email: KLNorris@cdc.gov
Information will be collected and analyzed by:
Michelle Owens-Gary, PhD
Centers for Disease Control and Prevention
Behavioral Scientist
Division of Diabetes Translation
770 Buford Highway, NE
Atlanta, GA 30341
Phone: 770-488-5014
Email: MOwens1@cdc.gov
Sarah Lewis, MPH
Centers for Disease Control and Prevention
ORISE Fellow
Division of Diabetes Translation
770 Buford Highway, NE
Atlanta, GA 30341
Phone: 770-488-5367
Email: ATaylorEllis@cdc.gov
| File Type | application/msword |
| File Title | Supporting Statement |
| Author | mgo2 |
| Last Modified By | arp5 |
| File Modified | 2009-11-05 |
| File Created | 2009-11-05 |